NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT), announced today that it will deliver a poster presentation at the 14th Annual Meeting of the American Society of Gene & Cell Therapy. The conference will be held May 18-21, 2011 at the Washington State Convention Center in Seattle, Washington. The Company will present during the Late Abstract Session II, which will begin Friday, May 20, at 4:40 P.M. Eastern Time. The poster presentation, entitled “Optimization of DNA to siRNA Ratio in SNS01 – an eIF5A-Based Gene Therapy Nanoparticle Designed for the Treatment of Multiple Myeloma”, will describe the properties of SNS01-T and be delivered by Catherine Taylor, from Senesco CSO John Thompson’s research laboratory at the University of Waterloo in Ontario, Canada. Additional details about the conference can be found at: http://www.asgct.org
